Anti-CCL2 (Carlumab)-SMCC-DM1 Preis auf Anfrage

Produktübersicht

• Artikelname: Anti-CCL2 (Carlumab)-SMCC-DM1 Preis auf Anfrage
• Artikelnummer: TGM-T9901A-1088
• Hersteller Artikelnummer: T9901A-1088
• Alternativnummer: TGM-T9901A-1088-1MG,TGM-T9901A-1088-5MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien

Produktbeschreibung

Anti-CCL2 (Carlumab)-SMCC-DM1 is an antibody-drug conjugate (ADC) consisting of the human-derived anti-CCL2 (chemokine ligand 2) antibody Carlumab linked to the cytotoxic microtubule inhibitor DM1 through the linker SMCC. The ADCs toxic molecule and linker component are SMCC-DM1. This compound is applicable in cancer research, particularly for studying prostate cancer.

Produkteigenschaften

• Target-Kategorie: Antibody-Drug Conjugates (ADCs)|||CCR|||Microtubule Associated